Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrand Architek. Regulatory News (BAR)

  • This share is currently suspended. It was suspended at a price of 47.50
  • There is currently no data for BAR

Form 8.5 (EPT/RI)

21 Apr 2022 09:14

RNS Number : 8907I
Singer Capital Markets Sec Ltd
21 April 2022
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Singer Capital Markets Securities Ltd

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

BRAND ARCHITEKTS GROUP PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

BRAND ARCHITEKTS GROUP PLC

(d) Date dealing undertaken:

20 April 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

YES

If YES, specify which:

 

InnovaDerma PLC

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 5P

 

 

Sale

 

65

 

75.9p

 

75.9p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

21 April 2022

Contact name:

Sarah-Rose Perry, Jennifer Bentick

Telephone number:

020 7496 3093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERUARWRUBUSURR
Date   Source Headline
15th Mar 20217:00 amRNSHolding(s) in Company
12th Mar 20211:04 pmRNSHolding(s) in Company
11th Mar 20214:18 pmRNSHolding(s) in Company
9th Mar 20211:04 pmRNSDirector/PDMR Shareholding
9th Mar 20217:00 amRNSHalf-year Report
25th Nov 20202:52 pmRNSResult of AGM
19th Nov 202012:04 pmRNSDirector/PDMR Shareholding
26th Oct 20202:55 pmRNSAnnual Report and Accounts & Notice of AGM
15th Oct 20209:46 amRNSHolding(s) in Company
12th Oct 20203:41 pmRNSHolding(s) in Company
30th Sep 20204:24 pmRNSGrant of share options
29th Sep 20205:10 pmRNSHolding(s) in Company
29th Sep 20203:00 pmRNSHolding(s) in Company
29th Sep 20209:59 amRNSHolding(s) in Company
29th Sep 20209:53 amRNSDirector/PDMR Shareholding
28th Sep 20207:00 amRNSFinal Results
31st Jul 202011:10 amRNSHolding(s) in Company
21st Jul 20203:27 pmRNSHolding(s) in Company
21st Jul 202010:45 amRNSHolding(s) in Company
20th Jul 202010:21 amRNSHolding(s) in Company
17th Jul 202011:02 amRNSDirector/PDMR Shareholding
14th Jul 20207:00 amRNSTrading Update and Board Succession
22nd May 20207:00 amRNSVesting of LTIP Award and Total Voting Rights
15th Apr 20207:00 amRNSAppointment of CFO
14th Apr 20207:00 amRNSTrading Update
10th Mar 20207:00 amRNSHalf-year Report
25th Feb 20207:00 amRNSBoard Changes
26th Nov 20195:44 pmRNSHolding(s) in Company
20th Nov 20191:03 pmRNSResult of AGM
20th Nov 20197:00 amRNSAGM Statement
6th Nov 20194:34 pmRNSAGM Proxy Form
25th Oct 20195:35 pmRNSPosting of Annual Report & Notice of AGM
24th Oct 20197:00 amRNSAppointment of Interim CEO
30th Sep 20197:00 amRNSFinal Results
28th Aug 20194:16 pmRNSUpdate on Change of Name
27th Aug 20196:00 pmRNSUpdate on Change of Name
27th Aug 20198:52 amRNSCompletion of Proposed Disposal and Change of Name
19th Aug 201912:50 pmRNSHolding(s) in Company
15th Aug 20199:17 amRNSHolding(s) in Company
31st Jul 201910:45 amRNSResult of General Meeting
15th Jul 20197:00 amRNSProposed Disposal of Manufacturing Business
12th Jul 201911:43 amRNSHolding(s) in Company
4th Jul 20193:41 pmRNSHolding(s) in Company
22nd May 201912:17 pmRNSHolding(s) in Company
13th May 20197:00 amRNSDirectorate Change
4th Apr 20196:29 pmRNSHolding(s) in Company
20th Mar 20193:17 pmRNSHolding(s) in Company
11th Mar 201911:59 amRNSHolding(s) in Company
7th Mar 20191:26 pmRNSHolding(s) in Company
5th Mar 20197:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.